Literature DB >> 18463933

Addition of nitric oxide through nitric oxide-paracetamol enhances healing rat achilles tendon.

George A C Murrell1, Gongyao Tang, Richard C Appleyard, Piero del Soldato, Min-Xia Wang.   

Abstract

Nitric oxide is an important messenger molecule in many physiological processes. The addition of NO via NO-flurbiprofen enhances the material properties of healing tendon, however, flurbiprofen has a detrimental effect on healing. We asked if NO delivered by a cyclooxygenase 3 inhibitor (paracetamol/acetaminophen) would enhance healing in a rat Achilles tendon healing model. Rats were injected subcutaneously daily with NO-paracetamol, paracetamol or vehicle from two days before surgery to the day of tissue harvesting. Paracetamol had no effect on tendon healing compared with vehicle alone. NO-paracetamol did not change the failure load, but did decrease the water content, enhance the collagen content, reduce the cross-sectional area and improve the ultimate stress of healing tendon compared with paracetamol and vehicle. The collagen organization of the healing tendon in the NO-paracetamol group, as determined by polarized light microscopy, was enhanced. Our data suggests NO-paracetamol increases the total collagen content and enhances organization while decreasing the cross-sectional area of healing rat Achilles tendon and is consistent with human clinical trials where NO has improved the symptoms and signs of tendinopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463933      PMCID: PMC2505261          DOI: 10.1007/s11999-008-0271-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  The cell specific temporal expression of nitric oxide synthase isoforms during achilles tendon healing.

Authors:  J Lin; M X Wang; A Wei; W Zhu; G A Murrell
Journal:  Inflamm Res       Date:  2001-10       Impact factor: 4.575

Review 2.  Determination of hydroxyproline.

Authors:  H Stegemann; K Stalder
Journal:  Clin Chim Acta       Date:  1967-11       Impact factor: 3.786

Review 3.  Nitric-oxide releasing molecules: a new class of drugs with several major indications.

Authors:  J L Burgaud; J P Riffaud; P Del Soldato
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

4.  Addition of nitric oxide via nitroflurbiprofen enhances the material properties of early healing of young rat Achilles tendons.

Authors:  J Yuan; G A C Murrell; A-Q Wei; R C Appleyard; P Del Soldato; M-X Wang
Journal:  Inflamm Res       Date:  2003-06       Impact factor: 4.575

5.  Achilles tendon injuries: a comparison of surgical repair versus no repair in a rat model.

Authors:  G A Murrell; E G Lilly; A Collins; A V Seaber; R D Goldner; T M Best
Journal:  Foot Ankle       Date:  1993-09

6.  Topical glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathy. A randomized, double-blind, placebo-controlled trial.

Authors:  Justin A Paoloni; Richard C Appleyard; Janis Nelson; George A C Murrell
Journal:  J Bone Joint Surg Am       Date:  2004-05       Impact factor: 5.284

7.  Nitric oxide enhances experimental wound healing in diabetes.

Authors:  M B Witte; T Kiyama; A Barbul
Journal:  Br J Surg       Date:  2002-12       Impact factor: 6.939

8.  Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter.

Authors:  H Bult; G E Boeckxstaens; P A Pelckmans; F H Jordaens; Y M Van Maercke; A G Herman
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

9.  Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow: a randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Justin A Paoloni; Richard C Appleyard; Janis Nelson; George A C Murrell
Journal:  Am J Sports Med       Date:  2003 Nov-Dec       Impact factor: 6.202

Review 10.  Nitric oxide in cardiovascular disorders.

Authors:  G J Dusting
Journal:  J Vasc Res       Date:  1995 May-Jun       Impact factor: 1.934

View more
  8 in total

Review 1.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

2.  Microcirculatory effects of topical glyceryl trinitrate on the Achilles tendon microcirculation in patients with previous Achilles tendon rupture.

Authors:  Rafal Osadnik; Joern Redeker; Robert Kraemer; Peter M Vogt; Karsten Knobloch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-31       Impact factor: 4.342

Review 3.  Endothelial dysfunction and tendinopathy: how far have we come?

Authors:  R Papalia; L Moro; F Franceschi; E Albo; S D'Adamio; A Di Martino; G Vadalà; C Faldini; V Denaro
Journal:  Musculoskelet Surg       Date:  2013-08-02

Review 4.  Pathogenesis of tendinopathies: inflammation or degeneration?

Authors:  Michele Abate; Karin Gravare Silbernagel; Carl Siljeholm; Angelo Di Iorio; Daniele De Amicis; Vincenzo Salini; Suzanne Werner; Roberto Paganelli
Journal:  Arthritis Res Ther       Date:  2009-06-30       Impact factor: 5.156

5.  Tendinosis: pathophysiology and nonoperative treatment.

Authors:  Christopher Kaeding; Thomas M Best
Journal:  Sports Health       Date:  2009-07       Impact factor: 3.843

Review 6.  Role of VEGF, Nitric Oxide, and Sympathetic Neurotransmitters in the Pathogenesis of Tendinopathy: A Review of the Current Evidences.

Authors:  Sebastiano Vasta; Alberto Di Martino; Biagio Zampogna; Guglielmo Torre; Rocco Papalia; Vincenzo Denaro
Journal:  Front Aging Neurosci       Date:  2016-08-09       Impact factor: 5.750

7.  Prolonged low-dose cyclophosphamide treatment after pulse therapy attenuates lung injury in rats with paraquat intoxication.

Authors:  Jie Gao; Shunyi Feng; Yong Li
Journal:  Korean J Intern Med       Date:  2018-05-31       Impact factor: 2.884

Review 8.  Glyceryl trinitrate patches-An alternative treatment for shoulder impingement syndrome.

Authors:  Yusuf Assem; Manit Arora
Journal:  J Orthop Translat       Date:  2014-12-12       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.